Unhealthy lifestyle impacts on biological systems involved in stress response: hypothalamic–pituitary–adrenal axis, inflammation and autonomous nervous system

An unhealthy lifestyle has a critical role in the pathogenesis and course of several chronic disorders. It has been hypothesized that lifestyle may also impact biological systems involved in stress response. A global index of unhealthy lifestyle was calculated based on the cumulative presence of five self-reported lifestyle habits (smoking, excessive alcohol use, drug use, low physical activity and short sleep) in 2783 participants (18–65 years) from the Netherlands Study of Depression and Anxiety. The functioning of biological stress systems was based on multiple physiological measures of cortisol, inflammatory cytokines and autonomic cardiac activity. The unhealthy lifestyle index was associated with hyperactivity of hypothalamus–pituitary–adrenal axis and increased inflammation, indicating that with increasing unhealthy habits, the level of biological stress increases. No association with the autonomic nervous system activity was observed; however, the use of drugs increased parasympathetic cardiac activity and significantly impacted on ANS. Results were not impacted by a recent episode of depression or anxiety disorder. An unhealthy lifestyle may unfavorably impact on biological systems involved in stress response, which may underlie progression of several psychiatric as well as somatic chronic disorders.

[1]  F. Benedetti,et al.  Antidepressant psychopharmacology: is inflammation a future target? , 2022, International clinical psychopharmacology.

[2]  F. Hoffmann,et al.  Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study , 2022, International clinical psychopharmacology.

[3]  D. Baldwin,et al.  Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study , 2021, International clinical psychopharmacology.

[4]  N. Veronese,et al.  Multiple lifestyle factors and depressed mood: a cross-sectional and longitudinal analysis of the UK Biobank (N = 84,860) , 2020, BMC Medicine.

[5]  B. Penninx,et al.  Childhood trauma and dysregulation of multiple biological stress systems in adulthood: Results from the Netherlands Study of Depression and Anxiety (NESDA) , 2020, Psychoneuroendocrinology.

[6]  M. Hotopf,et al.  Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption , 2020, Psychological Medicine.

[7]  M. Elbejjani,et al.  The association of antidepressant monotherapy and weight change in a Middle Eastern psychiatric population , 2020, International clinical psychopharmacology.

[8]  E. Vieta,et al.  mHealth in affective disorders: hype or hope? A focused narrative review. , 2020, International clinical psychopharmacology.

[9]  A. Fahimi,et al.  Immune and Neuroprotective Effects of Physical Activity on the Brain in Depression , 2018, Front. Neurosci..

[10]  R. Sinha,et al.  Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders , 2017, Neuropharmacology.

[11]  Susan Redline,et al.  Insomnia and Risk of Cardiovascular Disease. , 2017, Chest.

[12]  R. Arena,et al.  The Current Global State of Key Lifestyle Characteristics: Health and Economic Implications. , 2017, Progress in cardiovascular diseases.

[13]  Chong Chen,et al.  The exercise-glucocorticoid paradox: How exercise is beneficial to cognition, mood, and the brain while increasing glucocorticoid levels , 2017, Frontiers in Neuroendocrinology.

[14]  Femke Lamers,et al.  Influences of lifestyle factors on cardiac autonomic nervous system activity over time. , 2017, Preventive medicine.

[15]  T. Guiraud,et al.  Exercise training-induced modification in autonomic nervous system: An update for cardiac patients. , 2017, Annals of physical and rehabilitation medicine.

[16]  Hong Peng,et al.  Are healthy smokers really healthy? , 2016, Tobacco induced diseases.

[17]  L. Briand,et al.  Substance use modulates stress reactivity: Behavioral and physiological outcomes , 2016, Physiology & Behavior.

[18]  M. Grandner,et al.  Sleep Duration and Diabetes Risk: Population Trends and Potential Mechanisms , 2016, Current Diabetes Reports.

[19]  L. Vendruscolo,et al.  Divergent regulation of distinct glucocorticoid systems in alcohol dependence. , 2015, Alcohol.

[20]  Luca Carnevali,et al.  Autonomic dysfunction and heart rate variability in depression , 2015, Stress.

[21]  A. Mouton,et al.  Alcohol effects on cardiac function. , 2015, Comprehensive Physiology.

[22]  H. Graham,et al.  Characteristics of Interventions Targeting Multiple Lifestyle Risk Behaviours in Adult Populations: A Systematic Scoping Review , 2015, PloS one.

[23]  B. Penninx,et al.  Sleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands Study of Depression and Anxiety (NESDA). , 2015, Journal of psychiatric research.

[24]  Katsuhiko Suzuki,et al.  Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects. , 2015, Exercise immunology review.

[25]  H. Middlekauff,et al.  Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. , 2014, Journal of the American College of Cardiology.

[26]  N. Kiguchi,et al.  Nicotine effects and the endogenous opioid system. , 2014, Journal of pharmacological sciences.

[27]  A. O'Neil,et al.  Lifestyle medicine for depression , 2014, BMC Psychiatry.

[28]  R. Harris,et al.  Neuroimmune mechanisms of alcohol and drug addiction. , 2014, International review of neurobiology.

[29]  M. Maes,et al.  So depression is an inflammatory disease, but where does the inflammation come from? , 2013, BMC Medicine.

[30]  U. Nater,et al.  Biomarkers of stress in behavioural medicine , 2013, Current opinion in psychiatry.

[31]  F. Zitman,et al.  Salivary cortisol levels and the 2-year course of depressive and anxiety disorders , 2013, Psychoneuroendocrinology.

[32]  A. O'Neil,et al.  The association between diet quality, dietary patterns and depression in adults: a systematic review , 2013, BMC Psychiatry.

[33]  D. Aizenbud,et al.  Cigarette smoking and inflammation revisited , 2013, Respiratory Physiology & Neurobiology.

[34]  A. Beekman,et al.  Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression , 2013, Molecular Psychiatry.

[35]  P. Drummond,et al.  A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. , 2013, Journal of affective disorders.

[36]  F. Zitman,et al.  The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression , 2013, Psychoneuroendocrinology.

[37]  B. Penninx,et al.  Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: Findings from the Netherlands Study of Depression and Anxiety (NESDA) , 2010, Psychoneuroendocrinology.

[38]  D. A. Silva,et al.  Clustering of risk behaviors for chronic noncommunicable diseases: a population-based study in southern Brazil. , 2013, Preventive medicine.

[39]  B. Penninx,et al.  Dysregulation of the autonomic nervous system and its association with the presence and intensity of chronic widespread pain , 2012, Arthritis care & research.

[40]  B. Penninx,et al.  Effects of Antidepressants, but not Psychopathology, on Cardiac Sympathetic Control: A Longitudinal Study , 2012, Neuropsychopharmacology.

[41]  A. Beekman,et al.  Association of depressive disorders, depression characteristics and antidepressant medication with inflammation , 2012, Translational Psychiatry.

[42]  A. Beekman,et al.  Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. , 2011, Drug and alcohol dependence.

[43]  R. Walsh,et al.  and Mental Health , 2022 .

[44]  A. Möller-Leimkühler.  Higher comorbidity of depression and cardiovascular disease in women: A biopsychosocial perspective , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[45]  F. Zitman,et al.  Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. , 2009, Archives of general psychiatry.

[46]  Rajita Sinha,et al.  Chronic Stress, Drug Use, and Vulnerability to Addiction , 2008, Annals of the New York Academy of Sciences.

[47]  P. Cuijpers,et al.  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods , 2008, International journal of methods in psychiatric research.

[48]  Wouter Poortinga,et al.  The prevalence and clustering of four major lifestyle risk factors in an English adult population. , 2007, Preventive medicine.

[49]  T. Roth,et al.  Insomnia: pathophysiology and implications for treatment. , 2007, Sleep medicine reviews.

[50]  W. Lovallo.  Cortisol secretion patterns in addiction and addiction risk. , 2006, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[51]  C. Kirschbaum,et al.  The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers. , 2006, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[52]  Andrew H. Miller,et al.  Cytokines sing the blues: inflammation and the pathogenesis of depression. , 2006, Trends in immunology.

[53]  E. J. Geus,et al.  Effects of variation in posture and respiration on RSA and pre-ejection period. , 2005, Psychophysiology.

[54]  Bronya Vaschillo,et al.  Heartbeat synchronizes with respiratory rhythm only under specific circumstances. , 2004, Chest.

[55]  E. Coups,et al.  Physician screening for multiple behavioral health risk factors. , 2004, American journal of preventive medicine.

[56]  C. Kirschbaum,et al.  Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change , 2003, Psychoneuroendocrinology.

[57]  J. Romijn,et al.  Automated measurement of salivary cortisol. , 2003, Clinical chemistry.

[58]  V. Somers,et al.  Arterial baroreflex function and cardiovascular variability: interactions and implications. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[59]  A. Schuit,et al.  Clustering of lifestyle risk factors in a general adult population. , 2002, Preventive medicine.

[60]  E. Bixler,et al.  Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. , 2001, The Journal of clinical endocrinology and metabolism.

[61]  Y. Shaham,et al.  The role of corticotropin-releasing factor in drug addiction. , 2001, Pharmacological reviews.

[62]  H. Karagueuzian.  Consensus Statement from the Cardiac Nomenclature Study Group of Arrhythmias of the European Society of Cardiology, and the Task Force on Cardiac Nomenclature from the North American Society of Pacing and Electrophysiology on Living Anatomy of the Atrioventricular Junctions , 2000 .

[63]  K. Spiegel,et al.  Impact of sleep debt on metabolic and endocrine function , 1999, The Lancet.

[64]  E. Bosmans,et al.  The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. , 1998, Cytokine.

[65]  G. Andrews,et al.  The psychometric properties of the Composite International Diagnostic Interview , 1998, Social Psychiatry and Psychiatric Epidemiology.

[66]  B. McEwen.  Protective and damaging effects of stress mediators. , 1998, The New England journal of medicine.

[67]  K. Tanaka,et al.  [Dexamethasone suppression test]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.

[68]  J. Cacioppo,et al.  Autonomic cardiac control. III. Psychological stress and cardiac response in autonomic space as revealed by pharmacological blockades. , 1994, Psychophysiology.

[69]  J. Born,et al.  Corticotropin-releasing hormone-induced adrenocorticotropin and cortisol secretion depends on sleep and wakefulness. , 1993, The Journal of clinical endocrinology and metabolism.

[70]  O. Aasland,et al.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. , 1993, Addiction.

[71]  D. Rao,et al.  Lifestyle factors in monozygotic and dizygotic twins , 1988, Genetic epidemiology.

[72]  B. Carroll.  DEXAMETHASONE SUPPRESSION TEST, 1984 , 1984 .